Correlation Between Hyperhomocysteinemia and Outcomes of Patients With Acute Myocardial Infarction
- 1 November 2016
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of Sport Medicine
- Vol. 23 (6), e1464-e1468
- https://doi.org/10.1097/mjt.0000000000000130
Abstract
Overwhelming clinical and epidemiological studies have identified elevated plasma total homocysteine (Hcy) as new important risk factor for atherosclerotic vascular disease. But the relationship between outcome and hyperhomocysteinemia in patients with acute myocardial infarction (AMI) has been rarely reported. This study aimed to evaluate the association between hyperhomocysteinemia and short-term outcomes of patients with AMI. Eight hundred five patients were divided into high Hcy level group (group H: N = 457) and low Hcy level group (group L: N = 348) according to the plasma Hcy levels of 15 mmol/L. The comparisons were made between 2 groups in the following aspects: sex, hypertension, diabetes, hyperlipidemia, the time for symptom from onset to percutaneous coronary intervention, homoccyteine, creatine phosphokinase isoenzyme (creatine kinase myocardial band), and the incidence of 30-day adverse events. The incidences of heart failure, cardiac rupture, death, and the total adverse cardiovascular events were statistically significantly higher in group H than in group L. But the incidence of postoperative angina pectoris and reinfarction was similar between groups. The results of logistic regression showed that the incidence of 30-day adverse events was closely related to the age and the level of Hcy. An elevated plasma total Hcy level in patients with AMI experienced pemutaneous coronary intervention may be related to the short-term outcomes. An elevated high plasma Hcy level also seems to be an independent predictor of 30-day cardiovascular events in patients with AMI.Keywords
This publication has 19 references indexed in Scilit:
- Innate immunity, macrophage activation, and atherosclerosisImmunological Reviews, 2007
- Homocysteine, vitamin B12 and folate levels in premature coronary artery diseaseBMC Cardiovascular Disorders, 2006
- Current and Future Directions of Cardiovascular Risk PredictionThe American Journal of Cardiology, 2006
- The role of increased levels of homocysteine in the development of cardiovascular diseasesMedicinski Pregled, 2006
- C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseasesMedical Hypotheses, 2004
- Homocysteine and cardiovascular disease: evidence on causality from a meta-analysisBMJ, 2002
- Association of plasma homocysteine with restenosis after percutaneous coronary angioplastyEuropean Heart Journal, 2002
- Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic EvidenceAnnals of Internal Medicine, 1999
- Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial diseaseJournal of Vascular Surgery, 1999
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997